Official health communications are failing PFAS-contaminated communities.

Fluorocarbons Health communication Per- and polyfluoroalkyl substances (PFAS) Secondary prevention Shared decision-making

Journal

Environmental health : a global access science source
ISSN: 1476-069X
Titre abrégé: Environ Health
Pays: England
ID NLM: 101147645

Informations de publication

Date de publication:
11 05 2022
Historique:
received: 07 12 2021
accepted: 12 04 2022
entrez: 10 5 2022
pubmed: 11 5 2022
medline: 14 5 2022
Statut: epublish

Résumé

Environmental health agencies are critical sources of information for communities affected by chemical contamination. Impacted residents and their healthcare providers often turn to federal and state agency webpages, fact sheets, and other documents to weigh exposure risks and interventions. This commentary briefly reviews scientific evidence concerning per- and polyfluoroalkyl substances (PFAS) for health outcomes that concern members of affected communities and that have compelling or substantial yet differing degree of scientific evidence. It then features official documents in their own language to illustrate communication gaps, as well as divergence from scientific evidence and from best health communication practice. We found official health communications mostly do not distinguish between the needs of heavily contaminated communities characterized by high body burdens and the larger population with ubiquitous but substantially smaller exposures. Most health communications do not distinguish levels of evidence for health outcomes and overemphasize uncertainty, dismissing legitimate reasons for concern in affected communities. Critically, few emphasize helpful approaches to interventions. We also provide examples that can be templates for improvement. Immediate action should be undertaken to review and improve official health communications intended to inform the public and health providers about the risks of PFAS exposure and guide community and medical decisions.

Sections du résumé

BACKGROUND
Environmental health agencies are critical sources of information for communities affected by chemical contamination. Impacted residents and their healthcare providers often turn to federal and state agency webpages, fact sheets, and other documents to weigh exposure risks and interventions.
MAIN BODY
This commentary briefly reviews scientific evidence concerning per- and polyfluoroalkyl substances (PFAS) for health outcomes that concern members of affected communities and that have compelling or substantial yet differing degree of scientific evidence. It then features official documents in their own language to illustrate communication gaps, as well as divergence from scientific evidence and from best health communication practice. We found official health communications mostly do not distinguish between the needs of heavily contaminated communities characterized by high body burdens and the larger population with ubiquitous but substantially smaller exposures. Most health communications do not distinguish levels of evidence for health outcomes and overemphasize uncertainty, dismissing legitimate reasons for concern in affected communities. Critically, few emphasize helpful approaches to interventions. We also provide examples that can be templates for improvement.
CONCLUSIONS
Immediate action should be undertaken to review and improve official health communications intended to inform the public and health providers about the risks of PFAS exposure and guide community and medical decisions.

Identifiants

pubmed: 35538533
doi: 10.1186/s12940-022-00857-9
pii: 10.1186/s12940-022-00857-9
pmc: PMC9092686
doi:

Substances chimiques

Fluorocarbons 0
Water Pollutants, Chemical 0

Types de publication

Letter Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

51

Subventions

Organisme : NIEHS NIH HHS
ID : P42 ES031009
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Arch Pediatr Adolesc Med. 2010 Sep;164(9):860-9
pubmed: 20819969
Am J Gastroenterol. 2017 Jan;112(1):18-35
pubmed: 27995906
Environ Res. 2021 Apr;195:110740
pubmed: 33460636
Int J Mol Sci. 2021 Jan 20;22(3):
pubmed: 33498193
Toxicology. 2017 Jul 15;387:95-107
pubmed: 28558994
Toxicology. 2021 Jul;459:152845
pubmed: 34246716
J Expo Sci Environ Epidemiol. 2019 Mar;29(2):131-147
pubmed: 30470793
Environ Health Perspect. 2020 Feb;128(2):27007
pubmed: 32068468
Toxicology. 2017 Mar 01;378:37-52
pubmed: 28049043
Environ Sci Technol Lett. 2020 Dec 8;7(12):903-908
pubmed: 33553465
Environ Res. 2016 Aug;149:239-246
pubmed: 27179585
Chemosphere. 2014 Mar;98:78-83
pubmed: 24238303
Environ Health. 2017 Nov 14;16(1):120
pubmed: 29132367
EFSA J. 2020 Sep 17;18(9):e06223
pubmed: 32994824
Environ Int. 2021 Jul;152:106496
pubmed: 33744484
Toxicol Appl Pharmacol. 2020 Dec 1;408:115250
pubmed: 32979393
PLoS Biol. 2017 Dec 20;15(12):e2002855
pubmed: 29261653
Endocrinology. 2021 Dec 1;162(12):
pubmed: 34480479
Environ Health. 2020 Mar 14;19(1):33
pubmed: 32169067
Environ Int. 2021 Dec;157:106855
pubmed: 34500360
Environ Health Perspect. 2009 Dec;117(12):1873-82
pubmed: 20049206
Nagoya J Med Sci. 2020 May;82(2):323-333
pubmed: 32581411
J Air Waste Manag Assoc. 2021 Oct;71(10):1265-1276
pubmed: 34609253
Environ Health Perspect. 2013 Nov-Dec;121(11-12):1313-8
pubmed: 24007715
Am J Gastroenterol. 2006 Jan;101(1):76-82
pubmed: 16405537
Chemosphere. 2020 Nov;259:127446
pubmed: 32590180
Environ Res. 2019 Dec;179(Pt A):108743
pubmed: 31542491
Environ Health Perspect. 2017 Mar;125(3):416-421
pubmed: 27529882
Curr Environ Health Rep. 2019 Sep;6(3):95-104
pubmed: 31090041
Environ Int. 2019 Dec;133(Pt A):105160
pubmed: 31518937
J Natl Cancer Inst. 2021 May 4;113(5):580-587
pubmed: 32944748
Environ Health Perspect. 2017 Oct 24;125(10):104502
pubmed: 29068316
Environ Pollut. 2021 Sep 1;284:117518
pubmed: 34261222
Environ Health Perspect. 2008 May;116(5):651-7
pubmed: 18470314
Int J Hyg Environ Health. 2020 Sep;230:113607
pubmed: 32919137
J Occup Environ Med. 2009 Mar;51(3):364-72
pubmed: 19225424
Int J Toxicol. 2021 Jul-Aug;40(4):355-366
pubmed: 33944624
Environ Int. 2022 Jan;158:106919
pubmed: 34634623
Am J Epidemiol. 2012 Nov 15;176(10):909-17
pubmed: 23079607
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e631-e642
pubmed: 34529060
Environ Toxicol Chem. 2021 Mar;40(3):550-563
pubmed: 32845526
Toxicol Sci. 2013 Dec;136(2):382-91
pubmed: 24014645
Toxicol Sci. 2021 May 27;181(2):199-214
pubmed: 33772556
Sci Rep. 2021 Jun 14;11(1):12490
pubmed: 34127778
Toxicol Pathol. 2015 Jun;43(4):558-68
pubmed: 25398757
Environ Toxicol Chem. 2021 Mar;40(3):606-630
pubmed: 33017053
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
Environ Sci Technol. 2020 Mar 17;54(6):3465-3475
pubmed: 32119782
Toxicol Sci. 2021 Jul 16;182(1):82-95
pubmed: 33844015
Environ Sci Process Impacts. 2020 Dec 1;22(12):2345-2373
pubmed: 33125022
Toxicol Appl Pharmacol. 2020 Oct 15;405:115204
pubmed: 32822737
Environ Health Perspect. 2010 Feb;118(2):229-33
pubmed: 20123605
Toxicol Appl Pharmacol. 2021 Sep 1;426:115644
pubmed: 34252412
Toxicol Lett. 2022 Mar 1;357:20-32
pubmed: 34958885
Hepatology. 2008 Apr;47(4):1363-70
pubmed: 18366115
Hepatology. 2006 May;43(5):1145-51
pubmed: 16628637
Environ Res. 2021 Mar;194:110690
pubmed: 33385391
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1259-1271
pubmed: 30403786
Environ Res. 2019 Apr;171:452-469
pubmed: 30739020
Environ Health Perspect. 2007 Nov;115(11):1596-602
pubmed: 18007991
Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1479-1492
pubmed: 30213782
Environ Justice. 2021 Aug 1;14(4):235-242
pubmed: 34484556
Scand J Work Environ Health. 2010 Sep;36(5):413-21
pubmed: 20200757
Hepatology. 2021 Mar;73(3):937-951
pubmed: 32416645
Environ Sci Technol Lett. 2016 Oct 11;3(10):344-350
pubmed: 27752509
Toxicol Sci. 2020 Dec 1;178(2):311-324
pubmed: 32991729
J Air Waste Manag Assoc. 2021 Jun;71(6):663-679
pubmed: 33780327
Environ Health Perspect. 2020 Jul;128(7):77005
pubmed: 32697103
Am J Epidemiol. 2009 Nov 15;170(10):1268-78
pubmed: 19846564
Regul Toxicol Pharmacol. 2021 Apr;121:104862
pubmed: 33444659
Crit Rev Toxicol. 2021 Feb;51(2):141-164
pubmed: 33853480
Environ Int. 2021 Feb;147:106333
pubmed: 33360412
J Occup Environ Med. 2007 Aug;49(8):872-9
pubmed: 17693785
Lancet Oncol. 2014 Aug;15(9):924-5
pubmed: 25225686
Environ Health Perspect. 2016 Aug;124(8):1227-33
pubmed: 26978841
Environ Res. 2021 Jun;197:111113
pubmed: 33823190
Reprod Toxicol. 2017 Mar;68:164-170
pubmed: 27421579
Int J Environ Res Public Health. 2018 Aug 05;15(8):
pubmed: 30081587
Environ Int. 2021 Dec;157:106843
pubmed: 34479135
Occup Environ Med. 2015 May;72(5):373-80
pubmed: 25601914
Environ Res. 2021 Jun;197:111183
pubmed: 33887277
Environ Res. 2022 May 1;207:112206
pubmed: 34653413

Auteurs

Alan Ducatman (A)

School of Public Health, West Virginia University, Morgantown, WV, USA. aducatman@hsc.wvu.edu.

Jonas LaPier (J)

Green Science Policy Institute, Berkeley, CA, USA.

Rebecca Fuoco (R)

Green Science Policy Institute, Berkeley, CA, USA.

Jamie C DeWitt (JC)

Brody School of Medicine, East Carolina University, Greenville, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH